2,3-diphosphoglycerate has been researched along with Arterial Occlusive Diseases in 3 studies
2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)
2,3-bisphosphoglyceric acid : A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cicco, G | 1 |
| van der Kleij, AJ | 1 |
| Passavanti, G | 1 |
| Baldassare, G | 1 |
| Manicone, A | 1 |
| Vicenti, P | 1 |
| Marra, M | 1 |
| Izzo, P | 1 |
| Coratelli, P | 1 |
| Pirelli, A | 1 |
| Giunta, R | 1 |
| Coppola, A | 1 |
| Luongo, C | 1 |
| Sammartino, A | 1 |
| Guastafierro, S | 1 |
| Grassia, A | 1 |
| Giunta, L | 1 |
| Mascolo, L | 1 |
| Tirelli, A | 1 |
| Coppola, L | 1 |
| Briguglio, F | 1 |
| Di Marco, V | 1 |
| Circosta, C | 1 |
| Padovano, I | 1 |
| Ragusa, S | 1 |
| Saija, A | 1 |
| Briguglio, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness and Cost-effectiveness of Ozone Therapy in Patients With Ischemic Heart Disease Refractory to Medical and Surgical Treatment: Randomized, Triple-blind Clinical Trial[NCT03660657] | Phase 2/Phase 3 | 1 participants (Actual) | Interventional | 2020-02-26 | Terminated (stopped due to Very low recruitment. During COVID-19 pandemic these are patients of high risk.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for 2,3-diphosphoglycerate and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease.
Topics: 2,3-Diphosphoglycerate; Aged; Arterial Occlusive Diseases; Blood Transfusion, Autologous; Blood Visc | 2001 |
2 other studies available for 2,3-diphosphoglycerate and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Effect of bicarbonate haemodialysis on peripheral oxygen availability in mild hypertensive patients.
Topics: 2,3-Diphosphoglycerate; Arterial Occlusive Diseases; Bicarbonates; Female; Glucosephosphate Dehydrog | 1997 |
Metabolic effects of buflomedil hydrochloride.
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Adenylyl Cyclases; Adult; Aged; Arterial Occlusive D | 1985 |